Balance Sheet Data

Neovacs S.A. (ALNEV.PA)

1.16 €

-0.17 (-12.78%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 1.421.3010.0733.096.761.110.540.270.130.06
Total Cash (%)
Account Receivables 0.095.742.831.601.810.240.120.060.030.01
Account Receivables (%)
Inventories 4.9200.1900.500.060.030.010.010
Inventories (%)
Accounts Payable 3.403.761.291.321.930.230.110.060.030.01
Accounts Payable (%)
Capital Expenditure -0.01-0-0.21-0.35-0.16-0.02-0.01-0.01-0-0
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.